Singapore markets closed

Straits Times Index
3,331.70
+5.42(+0.16%)
S&P 500
5,466.33
-2.97(-0.05%)
Dow
39,030.06
-82.10(-0.21%)
Nasdaq
17,771.52
+53.86(+0.30%)
Bitcoin USD
61,775.30
+61.07(+0.10%)
CMC Crypto 200
1,277.40
-6.38(-0.50%)

ITCI Aug 2024 65.000 put

OPR - OPR Delayed price. Currency in USD

Add to watchlist

0.8500

0.0000

(0.00%)

As of 11:20AM EDT. Market open.

Zacks
Intra-Cellular's (ITCI) Caplyta Boosts Sales, Dependence a Woe
Intra-Cellular (ITCI) is witnessing strong Caplyta sales, driven by an increasing prescription rate. However, the company is heavily dependent on Caplyta sales for growth, which is a concern.
Zacks
Biotech Stock Roundup: ITCI Up on Study Data, ZNTL, OVID Down on Updates & More News
Intra-Cellular Therapies (ITCI) and Zentalis Pharmaceuticals, Inc. (ZNTL) are in the spotlight following pipeline and regulatory updates, respectively.
Zacks
Intra-Cellular (ITCI) Up as Second Depression Study Meets Goals
Intra-Cellular (ITCI) gains 10% after achieving key goals in the second late-stage study evaluating lumateperone 42 mg as an adjunctive therapy to antidepressants for the treatment of MDD.